![EX-99.2 3 a09-14567_1ex99d2.htm EX-99.2 Exhibit 99.2 GRAPHIC May 29, 2009 New GI Drug Company focused on Drugs to treat GI Disorders and Diseases (SGYP.OB) GRAPHIC SYNERGY PHARMACEUTICALS, INC. Certain statements made in this ... EX-99.2 3 a09-14567_1ex99d2.htm EX-99.2 Exhibit 99.2 GRAPHIC May 29, 2009 New GI Drug Company focused on Drugs to treat GI Disorders and Diseases (SGYP.OB) GRAPHIC SYNERGY PHARMACEUTICALS, INC. Certain statements made in this ...](https://www.sec.gov/Archives/edgar/data/1347613/000110465909036358/g145671moi047.gif)
EX-99.2 3 a09-14567_1ex99d2.htm EX-99.2 Exhibit 99.2 GRAPHIC May 29, 2009 New GI Drug Company focused on Drugs to treat GI Disorders and Diseases (SGYP.OB) GRAPHIC SYNERGY PHARMACEUTICALS, INC. Certain statements made in this ...
![Study design and timeline FPFV: First patient first visit; LPFV: Last... | Download Scientific Diagram Study design and timeline FPFV: First patient first visit; LPFV: Last... | Download Scientific Diagram](https://www.researchgate.net/publication/318089370/figure/fig2/AS:667674430435343@1536197397889/Study-design-and-timeline-FPFV-First-patient-first-visit-LPFV-Last-patient-first.png)
Study design and timeline FPFV: First patient first visit; LPFV: Last... | Download Scientific Diagram
![Study timeline. FPFV, first patient first visit; LPFV, last patient... | Download Scientific Diagram Study timeline. FPFV, first patient first visit; LPFV, last patient... | Download Scientific Diagram](https://www.researchgate.net/publication/312512487/figure/fig2/AS:962768224141316@1606553240994/Study-timeline-FPFV-first-patient-first-visit-LPFV-last-patient-first-visit-LPLV.gif)
Study timeline. FPFV, first patient first visit; LPFV, last patient... | Download Scientific Diagram
![Study design and timeline FPFV: First patient first visit; LPFV: Last... | Download Scientific Diagram Study design and timeline FPFV: First patient first visit; LPFV: Last... | Download Scientific Diagram](https://www.researchgate.net/publication/318089370/figure/fig4/AS:667674430410763@1536197397933/Photodynamic-therapy-1-31-VEGF-Vascular-endothelial-growth-factor_Q320.jpg)
Study design and timeline FPFV: First patient first visit; LPFV: Last... | Download Scientific Diagram
![Study design and timeline FPFV: First patient first visit; LPFV: Last... | Download Scientific Diagram Study design and timeline FPFV: First patient first visit; LPFV: Last... | Download Scientific Diagram](https://www.researchgate.net/publication/318089370/figure/fig1/AS:511508921753600@1498964638794/Patient-flow-diagram_Q320.jpg)
Study design and timeline FPFV: First patient first visit; LPFV: Last... | Download Scientific Diagram
![Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study | BMJ Open Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/8/9/e022690/F2.large.jpg)
Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study | BMJ Open
![Industry Research Shows 97% of Companies to Increase Use of Real-world Patient Data for More Accurate Decision-making | Business Wire Industry Research Shows 97% of Companies to Increase Use of Real-world Patient Data for More Accurate Decision-making | Business Wire](https://mms.businesswire.com/media/20171107005745/en/623095/5/Projected_Increase_of_Clinical_Data_Usage_in_Three_Years.jpg)
Industry Research Shows 97% of Companies to Increase Use of Real-world Patient Data for More Accurate Decision-making | Business Wire
![Study design and timeline FPFV: First patient first visit; LPFV: Last... | Download Scientific Diagram Study design and timeline FPFV: First patient first visit; LPFV: Last... | Download Scientific Diagram](https://www.researchgate.net/publication/318089370/figure/fig2/AS:667674430435343@1536197397889/Study-design-and-timeline-FPFV-First-patient-first-visit-LPFV-Last-patient-first_Q320.jpg)
Study design and timeline FPFV: First patient first visit; LPFV: Last... | Download Scientific Diagram
![Slides for Consideration DIA Webinar 2. Trial Registry Process Development Pamela Rose RN, FNP, ASQ-CQMOE Director, Clinical Trial Information Registries. - ppt download Slides for Consideration DIA Webinar 2. Trial Registry Process Development Pamela Rose RN, FNP, ASQ-CQMOE Director, Clinical Trial Information Registries. - ppt download](https://images.slideplayer.com/41/11146973/slides/slide_24.jpg)
Slides for Consideration DIA Webinar 2. Trial Registry Process Development Pamela Rose RN, FNP, ASQ-CQMOE Director, Clinical Trial Information Registries. - ppt download
![Industry Survey Reveals Clinical Data Management Delays Are Slowing Trial Completion | Business Wire Industry Survey Reveals Clinical Data Management Delays Are Slowing Trial Completion | Business Wire](https://mms.businesswire.com/media/20170921005426/en/613951/5/Types_vs_Volume_of_Data.jpg)
Industry Survey Reveals Clinical Data Management Delays Are Slowing Trial Completion | Business Wire
![SSU FPFV Milestone Achieved as University of Colorado Enrolls First Patient in HDAC Inhibitor Trial for OKI-179 SSU FPFV Milestone Achieved as University of Colorado Enrolls First Patient in HDAC Inhibitor Trial for OKI-179](https://trialsitenews.com/wp-content/uploads/2019/06/USE-THIS-ONE-ONLY-TRIALSITENEWS-POSTS-64.png)